Pfizer partner Protalix soars on sale speculation

By Ryan McBride All options appear to be on the table for Protalix BioTherapeutics, maker of a rare disease drug partnered with Pfizer ($PFE). With pharma interest in rare-disease ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS